InsideArbitrage Event Driven Monitor – May 15, 2025

Merger Arbitrage

1. BLUE: bluebird bio (BLUE) amended its definitive agreement with Carlyle (CG) and SK Capital. Under the amended agreement, bluebird stockholders can elect to receive either the original offer of $3 per share in cash plus a contingent value right (CVR) of $6.84 per share in cash payable upon achievement of a net sales milestone or $5 per share in cash.
2. DNB: Dun & Bradstreet (DNB) filed a definitive proxy statement. The special meeting of shareholders will be held on June 12, 2025.
3. WBA: Walgreens Boots Alliance (WBA) filed the preliminary proxy statement for its acquisition by Sycamore Partners. The company expects the merger to be completed during the fourth quarter of 2025.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.